How this application is scored, and how to structure it
Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)
National Institutes of Health
General proposal structure
This opportunity is not an NIH R/F/K mechanism (or we could not identify one), so no NIH scoring framework is asserted. Always follow the funder's own published criteria — the structure below is a sane default, not their rubric.
Set by the funder — check the announcement.
This funder does not publish review criteria that we could read, so the structure below is general best practice, not their rubric. Always follow the announcement.
What reviewers score
Significance / Fit
see announcement- Reviewers are asked
- Does this address something the funder cares about?
- So write
- Mirror the funder's own language about its priorities, and state the fit explicitly.
- Commonly loses points for
- Generic proposal with no evidence the announcement was read
Approach
see announcement- Reviewers are asked
- Is the plan rigorous and achievable?
- So write
- Design, controls, analysis, alternatives, timeline.
- Commonly loses points for
- No feasibility evidence
- No contingency
Team & Resources
see announcement- Reviewers are asked
- Can these people do it here?
- So write
- Map capabilities to people and facilities; include letters.
- Commonly loses points for
- Required expertise absent from the team
Section-by-section outline
1.Summary / Aims
1 pageThe standalone argument.
Must include
- Problem, gap, objective, aims, payoff
Avoid
- Methods presented as aims
2.Approach
Per announcementThe plan.
Must include
- Per aim: design, controls, statistics, alternatives
- Timeline
Avoid
- Overambitious scope
3.Team, Resources & Budget
Per announcementFeasibility.
Must include
- Who does what
- Instrument/facility access with letters
- Justified budget
Avoid
- Unjustified budget lines
Strategy notes for this mechanism
- Read the announcement's review criteria and restructure to match its headings exactly.
- Contact the programme contact listed in the announcement before writing.
Eligibility for this opportunity: This is a non-competitive funding opportunity intended to fund a single award. Through this single source, cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application to fund a single award to the current recipient of the Childhood Cancer Survivor Study.
Structure and review criteria are compiled from published funder guidance and were verified in July 2026. NIH revises these, so confirm against the current announcement before you submit. This is drafting scaffolding, not a substitute for your programme officer or research development office.